1. Home
  2. LSAK vs PROC Comparison

LSAK vs PROC Comparison

Compare LSAK & PROC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSAK
  • PROC
  • Stock Information
  • Founded
  • LSAK 1997
  • PROC 1976
  • Country
  • LSAK South Africa
  • PROC Luxembourg
  • Employees
  • LSAK N/A
  • PROC N/A
  • Industry
  • LSAK Investment Bankers/Brokers/Service
  • PROC Biotechnology: Pharmaceutical Preparations
  • Sector
  • LSAK Finance
  • PROC Health Care
  • Exchange
  • LSAK Nasdaq
  • PROC Nasdaq
  • Market Cap
  • LSAK 292.6M
  • PROC 283.2M
  • IPO Year
  • LSAK N/A
  • PROC N/A
  • Fundamental
  • Price
  • LSAK $4.83
  • PROC $2.50
  • Analyst Decision
  • LSAK
  • PROC Hold
  • Analyst Count
  • LSAK 0
  • PROC 1
  • Target Price
  • LSAK N/A
  • PROC $4.50
  • AVG Volume (30 Days)
  • LSAK 45.8K
  • PROC 3.9K
  • Earning Date
  • LSAK 09-10-2024
  • PROC 09-03-2024
  • Dividend Yield
  • LSAK N/A
  • PROC N/A
  • EPS Growth
  • LSAK N/A
  • PROC N/A
  • EPS
  • LSAK N/A
  • PROC 0.52
  • Revenue
  • LSAK $551,325,000.00
  • PROC $414,096,000.00
  • Revenue This Year
  • LSAK $9.63
  • PROC $5.54
  • Revenue Next Year
  • LSAK $8.35
  • PROC $8.54
  • P/E Ratio
  • LSAK N/A
  • PROC $4.83
  • Revenue Growth
  • LSAK 6.72
  • PROC N/A
  • 52 Week Low
  • LSAK $3.00
  • PROC $1.95
  • 52 Week High
  • LSAK $5.33
  • PROC $4.95
  • Technical
  • Relative Strength Index (RSI)
  • LSAK 56.10
  • PROC 43.73
  • Support Level
  • LSAK $4.64
  • PROC $2.50
  • Resistance Level
  • LSAK $4.84
  • PROC $2.81
  • Average True Range (ATR)
  • LSAK 0.15
  • PROC 0.11
  • MACD
  • LSAK -0.00
  • PROC 0.00
  • Stochastic Oscillator
  • LSAK 72.09
  • PROC 0.00

About LSAK Lesaka Technologies Inc.

Lesaka Technologies Inc provides payment solutions, transaction processing solutions, and financial technologies. The company operates two reportable segments: Merchant and Consumer. The company operates mainly within South Africa. The Merchant segment that derives majority revenue includes activities related to the provision of goods and services provided to corporate and other juristic entities. It earns fees from processing activities performed for its customers and revenue generated from the distribution of prepaid airtime. The Consumer segment includes activities related to the provision of financial services to customers, including bank accounts, loans, and insurance products. The firm charges monthly administration fees for all bank accounts.

About PROC Procaps Group S.A.

Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.

Share on Social Networks: